| EN

HKAPI Welcomes Four New Members to Advance the Pharmaceutical Industry in Hong Kong

We are excited to share that the Hong Kong Association of Pharmaceutical Industries (HKAPI) has welcomed four new members to our organization over the past year. These companies are bringing new and diverse expertise to our organization and we are thrilled to have them on board.

1. Johnson & Johnson Consumer (Hong Kong) Limited

Johnson & Johnson Consumer (Hong Kong) Limited is a subsidiary of Kenvue Inc., part of the Johnson & Johnson Family of Companies. Johnson & Johnson Consumer (Hong Kong) Limited is one of the world’s largest consumer health and personal care products companies.

2. Haleon

Haleon is a global leader in consumer health, with brands trusted by millions of consumers globally. The company is focused on delivering better everyday health with humanity and is dedicated to addressing real consumer health needs. Haleon’s portfolio of brands spans five major categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health and others, and Vitamins, Minerals, and Supplements (VMS).

3. Health Impact Consulting Limited

Health Impact Consulting Limited is a full-service healthcare consultancy with highly specialized experts in all spectrums of strategic healthcare communications. Their services include press relations, issue management and lobbying, media training for healthcare professionals, consumer communications, advertising, research,and digital marketing.

4. Illumina:

Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems dedicated to making genomics useful for all. The company is focused on innovating at the intersection of technology, biology, and health, and is dedicated to reimagining what’s possible for human health and the health of our planet. Illumina provides sequencing innovations that are enabling researchers and clinicians to usher in the future of personalized medicine.

Each of these companies brings unique expertise and experience to the HKAPI, and we are excited to work with them to advance the pharmaceutical industry in Hong Kong. We look forward to collaborating with our new members on initiatives aimed at improving patient access to innovative medicines, promoting research and development, and strengthening the regulatory environment for pharmaceuticals in Hong Kong.
Close Bitnami banner